Literature DB >> 1755833

Endothelin-1 is expressed and released by a human endothelial hybrid cell line (EA.hy 926).

O Saijonmaa1, T Nyman, U Hohenthal, F Fyhrquist.   

Abstract

A permanent vascular endothelial cell line, EA.hy 926, was shown to express endothelin-1 (ET-1) mRNA and to secrete big ET-1 and ET-1 into culture medium. The concentration of both big ET-1 and ET-1 was significantly increased in EA.hy 926 culture medium by phosphoramidon, a metalloproteinase inhibitor, suggesting that phosphoramidon sensitive protease(s) may be responsible for the degradation of ET-1 and big ET-1. EA.hy 926 cells responded to various regulators of ET-1 similarly as primary human vascular endothelial cells. The production of ET-1 was increased by thrombin and decreased by vasodilators such as atrial natriuretic peptide, brain natriuretic peptide and nitroprusside, and by 8-bromo cyclic GMP and papaverine. This continuous human endothelial hybrid cell line could facilitate studies of regulation of ET-1 production in human endothelial cells, which in primary cultures have limited replication potential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755833     DOI: 10.1016/0006-291x(91)91221-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Responses of HUVEC and EAhy926 to heparin and fibroblast growth factors.

Authors:  S Thomas; C J Robinson; E Gray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

2.  Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926.

Authors:  M A Pech-Amsellem; I Myara; I Pico; C Mazière; J C Mazière; N Moatti
Journal:  Experientia       Date:  1996-03-15

3.  Use of whole genome expression analysis in the toxicity screening of nanoparticles.

Authors:  Eleonore Fröhlich; Claudia Meindl; Karin Wagner; Gerd Leitinger; Eva Roblegg
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-04       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.